[1]
“Peculiarities of COVID-19 course in a multimorbid elderly patient (clinal case report)”, Journal of Pharmaceutical Negative Results, vol. 13, no. 3, pp. 659–661, Sep. 2022, doi: 10.47750/pnr.2022.13.03.097.